Login to Your Account

Risks, But Maybe Big Rewards

Telomerase, Stem Cells Bids: Geron's Profile Grows Higher

By Randall Osborne

Monday, July 23, 2007
Geron Corp.'s steady news trickle this summer presages a stronger flow as the year goes on, and an "analyst day" last week got a hosted peek into what's ahead next year, leaving Geron watchers optimistic but reservedly so. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription